A mouse model for juvenile doxorubicin-induced cardiac dysfunction
about
Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse modelsDissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1Cardiomyocyte death in doxorubicin-induced cardiotoxicityP53 inhibition exacerbates late-stage anthracycline cardiotoxicity.Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarctionApoptosis in Anthracycline CardiomyopathyGranulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes.Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligasesProtection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting proteinAqueous fish extract increases survival in the mouse model of cytostatic toxicity.Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.VEGF nanoparticles repair the heart after myocardial infarction.Effects of age on multidrug resistance protein expression and doxorubicin accumulation in cardiac and skeletal muscle.Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice.Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicityAnthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
P2860
Q28066019-2DDB8719-06C8-4AE3-AE95-25496426BDE8Q28546141-2879BAB0-8D66-40B8-BA21-507BE65E8B2FQ33604134-BD54485E-5B81-4CF9-90BA-5DBFB18AD593Q34048273-656599A9-BFF6-451A-9F36-5028DB1F7A85Q34956358-FFE1183E-AD86-4AAE-8F2C-2402D2D4DCF9Q35642302-B22892D0-C033-4A76-94C0-721E6C32203CQ35644254-2F50035A-0984-40BA-9FA5-A257C22A6E88Q36772298-01D15B6C-A607-421F-81CE-7F6A0411DAE6Q37024066-4E7CFAAE-D93F-4781-9A19-63978BDDB749Q37081203-50B44BD6-DCCB-45A7-A9CD-15F87AD2FCFFQ37372976-744D6E8A-0C7D-4185-A8F6-8CD0E8028E56Q50175255-23A5AEC4-1DF3-4B53-A71D-9ED792729F51Q51192184-6B068F4F-DF78-47C5-A1E7-6522F2B9CABEQ53641268-51050199-E107-44BD-9774-F560E70984C7Q54979863-69D8D07C-D608-487E-A625-5D513B8CE1E7Q54981841-7F858FA1-FD0A-4BD2-8185-D200B7233AD6Q58696664-30F7E8CF-C6A6-4BB9-BDAC-8E65BE6482FAQ58803993-7A9B6A96-5660-4754-B4B5-DA5F15A8F775
P2860
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@ast
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@en
A mouse model for juvenile doxorubicin-induced cardiac dysfunction.
@nl
type
label
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@ast
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@en
A mouse model for juvenile doxorubicin-induced cardiac dysfunction.
@nl
prefLabel
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@ast
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@en
A mouse model for juvenile doxorubicin-induced cardiac dysfunction.
@nl
P2093
P2860
P1433
P1476
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
@en
P2093
Loren J Field
R Mark Payne
Randall Caldwell
Weinian Shou
Wuqiang Zhu
P2860
P2888
P304
P356
10.1203/PDR.0B013E318184D732
P407
P577
2008-11-01T00:00:00Z
P6179
1043447665